be_ixf;ym_202411 d_23; ct_50

Latest Insights on ECL

Does This Line Signal a 16-Year Bear Market? Worst case scenario, we’re looking at a decade-plus of lower stock prices. That’s the bad news. And I’ll show exactly how we get to that conclusion in today’s issue...
Analysts Are WRONG About 2023 Earnings Let me be perfectly clear: This bear is NOT over. The bottom is NOT in. And Wall Street analysts are painting a dangerous picture for any investor naïve enough to listen to them...
It’s the End of the World for Stocks (And I’m Buying)
by Charles Mizrahi November 3, 2022 Investing, Real Talk, Stocks
When it comes to stock investing, bad news can often lead to bargain prices on great companies. Is now the time to start buying?
What's next for Ethereum after the Merge? The Merge: What’s Next for Ethereum? On September 15, Ethereum upgraded its network. But what were the actual effects of the Ethereum Merge, and what can we expect next from the world's second-biggest crypto?
What is the top biotech stock pick for 2023? The #1 Breakthrough Biotech Stock for 2023 CRISPR Therapeutics is dedicated to 2 things: genetics research and saving lives. find out why this biotech stock is our #1 pick for 2023!

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Thirteen of my positions are up well over 50% in less than a year since joining your service. Two are in the triple digits with several close behind. My personal money manager, who works for one of the largest banks in the country, is envious of my gains. I never dreamed this was possible. My trips to China to teach English to young Chinese students is now much more affordable. Thank you for your dedication and help.”

- Chris K.

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“Looks like I have finally found the right person to learn and grow from.”

- James

Share This